Danaher (DHR) stock: Winston Score and insider trades

§Winston Score History

Danaher makes scientific tools and equipment used in hospitals, laboratories, and factories around the world. Its products help scientists run medical tests, develop new drugs, and filter water — covering areas like diagnostics, life sciences research, and water quality. The company owns well-known brands such as Beckman Coulter, Cytiva, and Hach, and sells primarily to hospitals, pharmaceutical companies, and research institutions.

Danaher earns money by selling instruments upfront and then generating recurring revenue from the consumables, reagents, and software those instruments require — a model that keeps customers coming back. It operates globally, with significant revenue from North America, Europe, and Asia, and generates over $23 billion in annual sales. Its main competitive advantage is the "Danaher Business System," an internal operating framework focused on continuous improvement that has historically driven strong margins. The key risk is that life sciences spending by biotech and pharmaceutical companies has slowed since the post-pandemic boom, pressuring near-term revenue growth.

Politician Trades

37 trades / 12mo

18 Congressional buys and 19 sells on DHR in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.3% YoY

YoY Growth Rate

Slow revenue growth

Reported EPS Growth

+36.7% YoY

Quarterly reporting periods ended:

26 Sept 2025: $1.28

25 Sept 2026: $1.75

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

$1.6B/ year

→ Flat (+1% vs prior year)

6.5% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

11.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$5.7B cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Danaher Corporation is growing revenue at 8% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

58.5%

Premium pricing power — 58.5% gross margin

Profit after running costs

Operating Margin

19.0%

Healthy — 19.0% operating margin

Return on the money invested

ROCE

6.5%

Weak — 6.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+5.5%

Slow sales growth (+5.5% YoY)

Profit growth

EPS YoY

+25.4%

Earnings growing fast (+25.4% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

158%

Turns 158% of profit into real cash

Spare cash per sale

FCF Margin

22.4%

Converts sales into free cash efficiently (22.4%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.49

Conservative — low debt load (0.49)

Covers its interest

Interest Cover

35.74x

Comfortably covers interest (35.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

37.7x

Pricey — P/E 37.7

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

+16.6

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (37.7 → 21.0)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

0.75%

Small dividend — 0.75% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

+23.6%

Dividend growing fast (23.6% YoY)

Payout Ratio

23%

no trend

Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial

Danaher Corporation

§How the score breaks down

Share count falling — buybacks

§Winston Score History

Politician Trades

Growth Profile

Every number that matters to educated investors.

Quality

Growth

Cash Flow

Stability

Valuation

Dividends